AG
STIM icon

Algert Global’s Neuronetics STIM Stock Holding History

Algert Global’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17,730
Closed -$38K – 1247
2023
Q2 		$38K Hold
17,730
– – ﹤0.01% 1064
2023
Q1 		$52K Buy
17,730
+5,390
+44% +$27.2K ﹤0.01% 1103
2022
Q4 		$85K Buy
+12,340
New +$58.3K ﹤0.01% 1083
2022
Q3 		– Sell
-18,240
Closed -$59K – 1332
2022
Q2 		$59K Buy
18,240
+4,810
+36% +$14K ﹤0.01% 1146
2022
Q1 		$41K Buy
+13,430
New +$45.4K ﹤0.01% 1148
2021
Q1 		– Sell
-12,763
Closed -$142K – 525
2020
Q4 		$142K Hold
12,763
– – 0.04% 362
2020
Q3 		$62K Hold
12,763
– – 0.02% 369
2020
Q2 		$25K Sell
12,763
-5,080
-28% -$10.4K 0.01% 408
2020
Q1 		$34K Buy
+17,843
New +$55.8K 0.01% 388

Other funds holding STIM

ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Algert Global's STIM Position: Q3 2023 in Review

Algert Global sold out of Neuronetics (STIM) in Q3 2023, closing a stake of 17,730 shares — an estimated $38K sold.

Algert Global first reported a position in STIM in Q1 2020 and held it in 9 quarters. The position peaked at $142K in Q4 2020. 56 funds tracked by Wall St. Rank hold STIM as of Q3 2023.

  • Algert Global reported no remaining Neuronetics position as of Q3 2023 after selling out during the quarter.
  • Algert Global sold 17,730 Neuronetics shares in Q3 2023, an estimated $38K.
  • Algert Global first reported a position in Neuronetics in Q1 2020 and held it in 9 quarters.
  • Algert Global's Neuronetics position peaked at $142K in Q4 2020.
  • 56 funds tracked by Wall St. Rank held Neuronetics as of Q3 2023.

Based on Algert Global's 13F filing for Q3 2023, filed 13 Nov 2023.